A recent study showed that the incidence of central hypothyroidism was 8.7% among acromegaly patients, far lower than that in NFPA patients, which might result from the stimulation effect of GH/IGF-1 on thyroid function (9). The gene discussed is IGF1; the disease is non-functioning pituitary adenoma.